drugset / Trial / NCT00907257

A Study of Different Use Regimens Using Two Acne Treatments

NCT00907257

Phase 4 Completed 247 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.

Timeline

Start
2009-02
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified 5 % Topical
Subject Tretinoin Small molecule 0.04 % Topical

Indications